These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26214902)

  • 1. IS THE AMPLIFICATION OF c-MYC, MLL AND RUNX1 GENES IN AML AND MDS PATIENTS WITH TRISOMY 8, 11 AND 21 A FACTOR FOR A CLONAL EVOLUTION IN THEIR KARYOTYPE?
    Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
    Tsitol Genet; 2015; 49(3):25-32. PubMed ID: 26214902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
    Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOES THE PATTERN OF CLONAL EVOLUTION IN THE KARYOTYPE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES DEPEND ON THE TYPE OF THE PRIMARY CHROMOSOMAL ABERRATIONS?
    Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
    Tsitol Genet; 2015; 49(4):17-24. PubMed ID: 26419065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
    Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE
    Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.
    Wang SA; Jabbar K; Lu G; Chen SS; Galili N; Vega F; Jones D; Raza A; Kantarjian H; Garcia-Manero G; McDonnell TJ; Medeiros LJ
    Leukemia; 2010 Apr; 24(4):740-7. PubMed ID: 20072149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Sakhdari A; Tang Z; Ok CY; Bueso-Ramos CE; Medeiros LJ; Huh YO
    Cancer Genet; 2019 Oct; 238():18-22. PubMed ID: 31425921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine fluorescence in situ hybridization with the MLL probe does not reliably detect two separate signals on one chromosome 11 in patients with trisomy 11.
    Smith A; Robson L; Heaps LS; Sharma P; Dunlop L; Bhave A; Bradstock K
    Cancer Genet Cytogenet; 2001 Sep; 129(2):173-6. PubMed ID: 11566351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.
    Dicker F; Haferlach C; Sundermann J; Wendland N; Weiss T; Kern W; Haferlach T; Schnittger S
    Leukemia; 2010 Aug; 24(8):1528-32. PubMed ID: 20520634
    [No Abstract]   [Full Text] [Related]  

  • 9. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
    Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
    Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel.
    Alvarez S; Cigudosa JC
    Hematol Oncol; 2005 Mar; 23(1):18-25. PubMed ID: 16142824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
    Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
    Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
    Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
    Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F
    Blood; 2004 Jan; 103(1):229-35. PubMed ID: 12946992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal evolution to acute myeloblastic leukemia with MLL gene rearrangement from trisomy 8 clone.
    Katayama Y; Takimoto H; Fujii N; Kimura G; Omoto E; Harada M
    Leukemia; 1997 Aug; 11(8):1380-2. PubMed ID: 9264397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiprobe fluorescence in situ hybridization panel in detection of the common cytogenetic abnormalities of acute myeloid leukemia].
    Xu LL; Liu XL; Du QF; Song LL; Cao R; Wei YQ; Xu N; Zhang JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):324-6. PubMed ID: 21638933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features.
    Wang SA; Abruzzo LV; Hasserjian RP; Zhang L; Hu Y; Zhang Y; Zhao M; Galili N; Raza A; Medeiros LJ; Garcia-Manero G; Miranda RN
    Leuk Res; 2011 Mar; 35(3):351-7. PubMed ID: 20691474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-MYC amplification in a case of progression from MDS to AML (M2).
    de Souza Fernandez T; Silva ML; De Souza J; De Paula MT; Abdelhay E
    Cancer Genet Cytogenet; 1996 Feb; 86(2):183-4. PubMed ID: 8603353
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome.
    Kameoka J; Funato T; Obara Y; Kadowaki I; Yokoyama H; Kimura T; Tomiya Y; Yamada M; Ishikawa I; Takagawa M; Sasaki O; Kimura J; Harigae H; Miura I; Meguro K; Kaku M; Sasaki T
    Cancer Genet Cytogenet; 2001 Jan; 124(2):159-64. PubMed ID: 11172910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.